Severe thrombocytopenia as a presentation of thyrotoxicosis due to Graves-Basedow disease in a pregnant patient. Case report

Authors

  • Lenin Gonzalo Solano-Patiño Especialista en Medicina Interna, graduado de la Universidad Central del Ecuador, actualmente médico tratante del servicio de Alto Riesgo Obstétrico de HGONA.i https://orcid.org/0009-0003-6230-2063
  • Elisa Jácome-Sánchez Especialista en Medicina Interna, graduada de la Pontificia Universidad Católica del Ecuador, actualmente médico tratante del servicio de Alto Riesgo Obstétrico de HGONA. https://orcid.org/0000-0002-3185-9112
  • Omar Azael Arteaga-Castro Especialista en Ginecología y Obstetricia, graduado de la Pontificia Universidad Católica del Ecuador, actualmente médico tratante de Alto Riesgo Obstétrico de HGONA.

DOI:

https://doi.org/10.29166/rfcmq.v50i3.7782

Keywords:

thyrotoxicosis, Graves' disease, thrombocytopenia

Abstract

Introduction: Graves-Basedow's disease is an autoimmune entity, which in pregnancy has a low prevalence, whose clinical manifestations are secondary to thyrotoxicosis and in rare cases may have hematologic manifestations.

Objective: To describe the case of a pregnant woman with severe thrombocytopenia secondary to Graves-Basedow disease, its treatment during pregnancy and the clinical evolution of the mother-child binomial.

Case presentation: It is shown the clinical case of a 22-year-old female patient, 7 weeks pregnant, who presented vomiting up to 30 times a day, for 2 weeks, with self-limited episodes of epistaxis. She was diagnosed with thyrotoxicosis due to Graves' Basedow disease, associated with severe thrombocytopenia. Treatment included corticosteroids, antithyroid drugs, beta-blockers and immunomodulators.

Discussion: The association of severe thrombocytopenia and Graves' Basedow disease is uncommon, its diagnosis during pregnancy is a clinical challenge, since it is necessary to rule out other gestational disorders. Therapeutic options in the first trimester of pregnancy are limited by the increased risk of teratogenicity.

Conclusions: The correct and timely diagnosis of this disease, allowed pharmacological decisions to be made in accordance with gestational age, thus achieving a pregnancy at term without complications.  

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Jameson J, Mandel S, Weetman P. Capítulo 384: Tirotoxicosis [Internet]. En: Harrison: Principios de Medicina Interna. 21a ed. McGrawHill; 2023 [citado 23 enero de 2025]. p1–16 p. Available from: https://accessmedicina.mhmedical.com/content.aspx?bookid=2943&sectionid=252751259

Cooper D, Laurberg P. Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol [Internet]. 2013 [citado 23 enero de 2025];1(3):238–49. Available from: http://dx.doi.org/10.1016/S2213-8587(13)70086-X

Alexander E, Pearce E, Brent G, Brown R, Chen H, Dosiou C, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum. Thyroid [Internet]. 2017 [citado 23 enero de 2025];27(3):315–89. Available from: https://www.thyroid.org/professionals/ata-professional-guidelines/

Pincet L, Gorostidi F. Graves Disease Causing Pancytopenia: Case Report and Literature Review. Clin Med Insights Case Reports [Internet]. 2018 [citado 23 enero de 2025];11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069025/pdf/10.1177_1179547618781090.pdf

Lima C, Zantut D, Castro V, Tambascia M, Lorand-Metze I, Saad S, et al. Pancytopenia in untreated patients with Graves’ disease. Thyroid [Internet]. 2006 [citado 23 enero de 2025];16(4):403–9. Available from: https://www.liebertpub.com/doi/pdf/10.1089/thy.2006.16.403?download=true

Fernández M, Lillo E, Ticera E, Lavandaio H, González S. Pancitopenia como forma de presentación de Enfermedad de Graves. 2019 [citado 23 enero de 2025];15:2–5. Available from: https://bdigital.uncu.edu.ar/objetos_digitales/13792/04fernandez.pdf

Rahmathullah I, Umakanth M, Singhapathirane S. Non-myeloproliferative Pancytopenia: A Rare Presentation of Thyrotoxicosis. Cureus [Internet]. 2023 [citado 23 enero de 2025];15(2):1–7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024633/

Hymes K, Blum M, Lackner H, Karpatkin S. Easy bruising, thrombocytopenia, and elevated platelet immunoglobulin G in Graves’ disease and Hashimoto’s thyroiditis. Ann Intern Med [Internet]. 1981 [citado 23 enero de 2025];94(1):27–30. Available from: https://www.acpjournals.org/doi/10.7326/0003-4819-94-1-27?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub 0pubmed

Espinoza J, Vidaeff A, Pettker C, Simhan H. Hypertension and Preeclampsia - ACOG Practice Bulletin [Internet]. Vol. 135, ACOG. 2020 [citado 23 enero de 2025]. Available from: http://journals.lww.com/greenjournal

Sociedad Española de Ginecología y Obstetricia. Trastornos hipertensivos en la gestación. Guía de Asistencia Práctica. [Internet]. 2020 [cited 2025 Mar 23]. Available from: https://sego.es/documentos/progresos/v63-2020/n4/GAP-Trastornos hipertensivos gestacion.pdf

Published

2025-09-30

How to Cite

1.
Solano-Patiño LG, Jácome-Sánchez E, Arteaga-Castro OA. Severe thrombocytopenia as a presentation of thyrotoxicosis due to Graves-Basedow disease in a pregnant patient. Case report. Rev Fac Cien Med (Quito) [Internet]. 2025 Sep. 30 [cited 2025 Dec. 5];50(3). Available from: https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/7782